Analyst Confidence Remains High for IBM’s Strategic Direction

Market experts continue to express strong confidence in International Business Machines Corp. (IBM), citing its robust operational health and a pivotal strategic acquisition. This optimism was underscored on Thursday when analysts at Oppenheimer reaffirmed their ‘Outperform’ rating on the equity, maintaining a price target of $360. This projection implies a potential upside of approximately 19% from current trading levels. The bullish outlook is largely predicated on anticipated acceleration in IBM’s software segment by 2026, fueled by the planned $11 billion acquisition of Confluent.

The prospective Confluent deal is viewed as a central catalyst for future growth. IBM aims to leverage the acquisition to build a unified platform for real-time AI infrastructure within hybrid cloud Read more...